• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  ibalizumab
Trade Name:  Trogarzo
Date Designated:  10/20/2014
Orphan Designation:  Treatment of HIV-1 infection in treatment experienced adult patients with documented multi-antiretroviral class resistance and evidence of HIV-1 replication despite ongoing antiretroviral therapy
Orphan Designation Status:  Designated/Approved
Marketing Approval Date:  03/06/2018 
Approved Labeled Indication:  TROGARZO, in combination with other antiretroviral(s), is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug resistant HIV-1 infection failing their current antiretroviral regimen.
Exclusivity End Date:   03/06/2025
TaiMed Biologics, Inc.
2 Executive Circle
Irvine, California 92614

The sponsor address listed is the last reported by the sponsor to OOPD.